In one patient (Enza-1) with paired biopsy samples that were obtained from the same site (Fig 4A), a P81L mutation in CDKN2A was only detected in the resistant tumor (Figs 4B and 4C and Data Supplement). This evidence concerns the gene CDKN2A and neoplasm.